CRANBURY, N.J. (PRWEB) MARCH 16, 2020
The Lynx Group, a global strategic alliance of medical communications and education companies, is pleased to announce that its Journal of Hematology Oncology Pharmacy™ (JHOP) has been named the official publication of the Hematology/Oncology Pharmacy Association (HOPA). As part of this agreement, JHOP will serve as a platform through which HOPA members can disseminate original findings, exchange best practices and find support for its growing community.
“It’s an honor to know that HOPA and its members find value in JHOP,” says Russell Hennessy, Executive Vice President, the Lynx Group. “We are excited to partner with HOPA in this capacity and to continuing to provide JHOP subscribers with access to consistently high-quality content.”
David DeRemer, HOPA 2020/21 president says, “HOPA is looking forward to our alliance with the Lynx Group and being able to provide the hematology/ oncology pharmacy community with a most-valued resource like JHOP.”
Since its founding in 2011, JHOP has provided hematology and oncology pharmacists with peer-reviewed information relevant to hematologic and oncologic conditions. Content, which is written by and for industry professionals, aims to help the publication’s 5,000 subscribers optimize drug therapy for patients. JHOP is published six times a year.
About the Lynx Group (thelynxgroup.com)
The Lynx Group is a rapidly growing global strategic alliance of medical communications and education companies. Through its unique business model, The Lynx Group strives to provide pivotal and contemporary information and education for all stakeholders in healthcare.
The Lynx Group is the official association management and marketing company of the Academy of Oncology Nurse & Patient Navigators, Association for Value-Based Cancer Care, and Association for Oncology Practice Management.
About the Hematology/Oncology Pharmacy Association (hoparx.org)
Hematology/Oncology Pharmacy Association (HOPA) is a nonprofit, education-based organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates the best possible cancer care. HOPA supports research, provides education, encourages professional development and advocates for health policy issues that improve patient care. HOPA serves more than 2,700 members in the fields of oncology pharmacy, pharmacy administration, and research, and includes pharmacy residents, interns, and technicians specializing in hematology/oncology practice.
